Weijuan Shang

机构：Chinese Academy of Sciences, Wuhan Institute of Virology

发表论文 47 篇 · 总被引 2141 次 · h-index 25

代表论文

• Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives (2021 · Nature Communications · 被引 252)
• Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease (2021 · Nature Communications · 被引 198)
• High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors (2021 · Protein & Cell · 被引 158)
• Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2 (2021 · Cell Research · 被引 134)
• Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir (2023 · Nature Communications · 被引 114)
• Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein (2021 · Acta Pharmacologica Sinica · 被引 76)